April 3 (Reuters) - Cotinga Pharmaceuticals Inc:
* COTINGA PHARMACEUTICALS REPORTS FISCAL 2018 THIRD QUARTER FINANCIAL AND OPERATING RESULTS
* Q3 LOSS PER SHARE C$0.08
* COTINGA PHARMACEUTICALS - NO REVENUE FOR THREE- AND NINE-MONTH PERIODS ENDED JANUARY 31, 2018 OR IN COMPARATIVE PERIODS IN THE YEAR PRIOR Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.